Mavelertinib

Item number	Size	Delivery time	Price
TGM-T21322-1mg	1 mg	7 - 10 business days*	60.00€
TGM-T21322-5mg	5 mg	7 - 10 business days*	145.00€
TGM-T21322-10mg	10 mg	7 - 10 business days*	220.00€
TGM-T21322-1mL	1 ml	7 - 10 business days*	223.00€
TGM-T21322-25mg	25 mg	7 - 10 business days*	-
TGM-T21322-50mg	50 mg	7 - 10 business days*	-

If you have any questions, please use our Contact Form.
You can also order by e-mail: info@biomol.com
Larger quantity required? Request bulk

Description: Mavelertinib (PF-06747775) is an orally available, selective and potent EGFR... more

Close menu

Product information "Mavelertinib"

Description: Mavelertinib (PF-06747775) is an orally available, selective and potent EGFR tyrosine kinase (EGFR TKI) inhibitor with inhibitory effects on T790M/L858R and T790M/Del, and can be used in the study of oncology and respiratory diseases. Target: EGFR. Smiles: COc1nn(C)cc1Nc1nc(nc2n(C)cnc12)N1C[C@@H](F)[C@@H](C1)NC(=O)C=C. References: Planken S, et, al. Discovery of N-((3R,4R)-4-Fluoro-1-(6-((3-methoxy-1-methyl-1H-pyrazol-4-yl)amino)-9-methyl-9H-purin-2-yl)pyrrolidine-3-yl)acrylamide (PF-06747775) through Structure-Based Drug Design: A High Affinity Irreversible Inhibitor Targeting Onc

Keywords:	PF6747775, PF-06747775, PF 06747775, PFE-X775, PF-7775, PF 6747775
Supplier:	TargetMol
Supplier-Nr:	T21322

Properties

Application:	Targets epidermal growth factor receptor [EC:2.7.10.1] (EGFR, ERBB1)
MW:	415.42 D
Formula:	C18H22FN9O2

Database Information

CAS :	1776112-90-3\| Matching products
KEGG ID :	K04361 \| Matching products

Handling & Safety

Storage:	-20°C
Shipping:	+4°C (International: +4°C)

Caution
Our products are for laboratory research use only: Not for administration to humans!

Information about the product reference will follow. more

Close menu

You will get a certificate here

Go back

Read, write and discuss reviews... more

Close menu

Customer review for "Mavelertinib"

Write a review